Posted by SLS on March 21, 2019, at 13:45:09
In reply to Re: FDA approves Zulresso, posted by Hugh on March 21, 2019, at 0:24:34
Hi, Hugh.
> SAGE-217, the oral version of Zulresso, is expected to be approved by the FDA this spring or summer. If this happens, any physician in the US will be allowed to prescribe SAGE-217 off-label for major depressive disorder, bipolar disorder, anxiety, PTSD, insomnia.
Thanks for the update.
SAGE-217 = Zuranolone
- Sage Therapeutics
I just got done looking at this drug. It appears to work the same way as Zulresso. It acts as a GABA-A receptor positive modulator.
Have you seen anyone use pregnanolone?
- Scott
Some see things as they are and ask why.
I dream of things that never were and ask why not.- George Bernard Shaw
poster:SLS
thread:1103636
URL: http://www.dr-bob.org/babble/20190206/msgs/1103657.html